Brainsway (BWAY)
(Delayed Data from NSDQ)
$10.23 USD
+0.23 (2.30%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $10.21 -0.02 (-0.20%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BWAY 10.23 +0.23(2.30%)
Will BWAY be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for BWAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BWAY
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
Strong Segmental Performance to Drive Stryker's Q3 Earnings
BWAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
Here's Why Momentum in Brainsway (BWAY) Should Keep going
Other News for BWAY
Small early trial shows brain stimulation may slow Alzheimer symptoms, NBC says
Small early trial shows brain stimulation may slow Alzheimer symptoms, NBC says
BrainsWay Ltd (BWAY) Trading 6.25% Higher on Oct 17
BrainsWay Expands Deep TMS Reach in East Asia
Brainsway announces further expansion in East Asia with 15 new systems